CPHI & PMEC China

CPHI & PMEC China 2026 is scheduled for June 16–18, 2026 in Shanghai as an in-person trade event focused on pharmaceutical sourcing, manufacturing solutions and cross-segment partnerships across the pharma value chain. The official event listing confirms the start and end dates and identifies Shanghai New International Expo Center as the venue, aligning with the show’s positioning “at the heart of pharma” and its role as a meeting point where buyers and suppliers can concentrate procurement discussions, technical validation and commercial negotiations into a short, structured visit. Looking ahead to 2026, the organiser highlights a line-up of 3,600+ exhibitors and 110,000+ global attendees, which is commercially relevant because this scale typically increases supplier optionality and shortens comparison cycles for procurement teams working under time and qualification constraints.

CPHI & PMEC China frames its thematic proposition around the “building blocks of pharma” and the practical reality that modern medicines require integrated sourcing across materials, services and manufacturing engineering. The event narrative emphasises connecting with local and global manufacturers across specialisms and building partnerships where drug development, scale-up and supply continuity intersect, which is why the show structure is organised to support end-to-end procurement journeys rather than isolated product browsing. In 2026 messaging, the exhibitor zones explicitly signal a supply-chain logic that spans pharma ingredients and excipients, finished dosage, biotech and natural products alongside contract services, enabling buyers to align formulation choices with manufacturing capacity, compliance expectations and commercial reliability during the same visit.

The event is designed for trade professionals who need qualified counterparties for sourcing, manufacturing partnerships and technology adoption, ranging from pharmaceutical and biotech manufacturers to distributors, procurement leads, R&D and quality teams, and service organisations that enable outsourcing and scale. Public event descriptions position CPHI & PMEC China as a platform for supplier discovery and lead generation across multiple pharma specialisms, which implies an attendee mix where technical and commercial decision-makers co-exist, allowing meetings to move beyond introductions into specification review, documentation requirements and cooperation models. The organiser’s guidance and third-party listings also underline the breadth of specialisms covered at the show, reinforcing the expectation that visitors can run a consolidated agenda spanning ingredients, machinery, packaging and associated manufacturing services without fragmenting discussions across separate events.

CPHI & PMEC China 2026 presents a broad on-site zoning concept built to mirror industrial procurement categories across pharmaceutical manufacturing and supply. Official and third-party event materials consistently reference core sourcing areas such as pharma ingredients, pharma excipients and finished dosage, complemented by biotech and natural products, contract services, packaging and drug-delivery solutions and pharmaceutical machinery, which together cover both “what goes into the product” and “how the product is manufactured, packed and delivered.” For buyers, this breadth is operationally useful because qualification risk often sits at the interfaces between material specs, process capability and packaging performance, so the ability to cross-check suppliers and integrators on one floor reduces iteration cycles and improves the quality of first-round RFQs.

CPHI & PMEC China 2026 will take place at Shanghai New International Expo Center (SNIEC), and venue guidance published for the event specifies the address as 2345 Longyang Road, Pudong New Area (Pudong New District), Shanghai, China. This venue choice is typical for large-scale industrial exhibitions where exhibitors require predictable logistics, wide hall infrastructure and the capacity to host multiple concurrent zones and meeting flows. For visiting teams, a fixed SNIEC address supports practical trip planning, including meeting scheduling, freight coordination for samples and technical materials and time management across multiple halls, which is essential when the show is used as a compressed procurement sprint rather than a general awareness event.

CPHI & PMEC China is operated within the Informa Markets ecosystem, and official event pages state that the event is part of the Informa Markets Division of Informa PLC, which is consistent with the broader CPHI global portfolio positioning. For exhibitors and visitors, this organiser model typically translates into standardised onboarding, registration and safety procedures as well as structured resources that support international participation, including published visitor guidance and practical services such as visa invitation letter processes for registered attendees. In procurement terms, the organiser’s emphasis on measurable business outcomes aligns with the show’s value proposition: high-density lead generation and partnership building across the pharma supply chain in a controlled, trade-only environment.